nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Quinapril—SLC15A2—multiple sclerosis	0.036	0.508	CrCbGaD
Alvimopan—Benazepril—SLC15A2—multiple sclerosis	0.0313	0.442	CrCbGaD
Alvimopan—OPRM1—nerve—multiple sclerosis	0.0193	0.215	CbGeAlD
Alvimopan—OPRM1—brainstem—multiple sclerosis	0.00826	0.0925	CbGeAlD
Alvimopan—OPRD1—nervous system—multiple sclerosis	0.00635	0.0711	CbGeAlD
Alvimopan—OPRD1—central nervous system—multiple sclerosis	0.00611	0.0684	CbGeAlD
Alvimopan—OPRK1—nervous system—multiple sclerosis	0.00609	0.0681	CbGeAlD
Alvimopan—OPRK1—central nervous system—multiple sclerosis	0.00586	0.0656	CbGeAlD
Alvimopan—OPRK1—cerebellum—multiple sclerosis	0.00573	0.0641	CbGeAlD
Alvimopan—OPRM1—midbrain—multiple sclerosis	0.00527	0.0589	CbGeAlD
Alvimopan—OPRM1—spinal cord—multiple sclerosis	0.00514	0.0575	CbGeAlD
Alvimopan—OPRD1—brain—multiple sclerosis	0.00485	0.0543	CbGeAlD
Alvimopan—OPRK1—brain—multiple sclerosis	0.00465	0.0521	CbGeAlD
Alvimopan—OPRM1—nervous system—multiple sclerosis	0.00433	0.0485	CbGeAlD
Alvimopan—OPRM1—central nervous system—multiple sclerosis	0.00417	0.0467	CbGeAlD
Alvimopan—Ketoprofen—ALB—multiple sclerosis	0.0036	0.0508	CrCbGaD
Alvimopan—OPRM1—brain—multiple sclerosis	0.00331	0.037	CbGeAlD
Alvimopan—OPRD1—GPCR ligand binding—CNR1—multiple sclerosis	0.00192	0.00228	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—RGS1—multiple sclerosis	0.00191	0.00227	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCR3—multiple sclerosis	0.00187	0.00223	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00187	0.00222	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00184	0.00219	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00183	0.00218	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CCR1—multiple sclerosis	0.00182	0.00217	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00182	0.00217	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCR2—multiple sclerosis	0.00182	0.00217	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CCL5—multiple sclerosis	0.00182	0.00217	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—GPR65—multiple sclerosis	0.00181	0.00215	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.0018	0.00214	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.0018	0.00214	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00176	0.00209	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00176	0.00209	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—LINGO1—multiple sclerosis	0.00175	0.00208	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—GPR65—multiple sclerosis	0.00175	0.00208	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—POMC—multiple sclerosis	0.00173	0.00206	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00173	0.00206	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00171	0.00204	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL3—multiple sclerosis	0.0017	0.00203	CbGpPWpGaD
Alvimopan—OPRM1—Opioid Signalling—MAPK1—multiple sclerosis	0.0017	0.00202	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CNR1—multiple sclerosis	0.00168	0.002	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00168	0.002	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—RGS1—multiple sclerosis	0.00167	0.00199	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—S1PR1—multiple sclerosis	0.00166	0.00198	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCL13—multiple sclerosis	0.00166	0.00197	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCR1—multiple sclerosis	0.00166	0.00197	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—PTGER4—multiple sclerosis	0.00164	0.00195	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.00164	0.00195	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.0016	0.0019	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCR1—multiple sclerosis	0.0016	0.0019	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—TGFB1—multiple sclerosis	0.00159	0.0019	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—GPR65—multiple sclerosis	0.00159	0.00189	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCR3—multiple sclerosis	0.00158	0.00189	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—MAPK1—multiple sclerosis	0.00156	0.00186	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00156	0.00186	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00154	0.00184	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCR2—multiple sclerosis	0.00154	0.00183	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—LINGO1—multiple sclerosis	0.00153	0.00183	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00152	0.00181	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00152	0.00181	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TAGAP—multiple sclerosis	0.00152	0.00181	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—POMC—multiple sclerosis	0.00152	0.00181	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00151	0.0018	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CCL5—multiple sclerosis	0.00149	0.00177	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00149	0.00177	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—GPR65—multiple sclerosis	0.00148	0.00176	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCL13—multiple sclerosis	0.00145	0.00173	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCR1—multiple sclerosis	0.00145	0.00173	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00145	0.00172	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CNR1—multiple sclerosis	0.00142	0.00169	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—RGS1—multiple sclerosis	0.00141	0.00168	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00137	0.00164	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00135	0.00161	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCR1—multiple sclerosis	0.00135	0.00161	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00134	0.0016	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—GPR65—multiple sclerosis	0.00134	0.0016	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CCR5—multiple sclerosis	0.00134	0.00159	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TAGAP—multiple sclerosis	0.00133	0.00158	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—S1PR1—multiple sclerosis	0.00133	0.00158	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCL5—multiple sclerosis	0.0013	0.00155	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.0013	0.00155	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—LINGO1—multiple sclerosis	0.0013	0.00154	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—GPC5—multiple sclerosis	0.00129	0.00154	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.00128	0.00153	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00128	0.00152	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00125	0.00149	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.00123	0.00146	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.00123	0.00146	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00121	0.00144	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00121	0.00144	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.0012	0.00143	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL3—multiple sclerosis	0.00118	0.0014	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00118	0.0014	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00117	0.0014	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCR5—multiple sclerosis	0.00117	0.0014	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—S1PR1—multiple sclerosis	0.00116	0.00138	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PTGER4—multiple sclerosis	0.00114	0.00135	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GPC5—multiple sclerosis	0.00113	0.00135	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RGS1—multiple sclerosis	0.00113	0.00134	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	0.00112	0.00134	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.0011	0.00131	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	0.0011	0.00131	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.0011	0.00131	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	0.00108	0.00129	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	0.00107	0.00127	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	0.00107	0.00127	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00106	0.00126	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	0.00105	0.00125	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL3—multiple sclerosis	0.00103	0.00123	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00103	0.00123	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	0.00102	0.00122	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00102	0.00121	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000997	0.00119	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000995	0.00119	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000993	0.00118	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RGS1—multiple sclerosis	0.000989	0.00118	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	0.000984	0.00117	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.000983	0.00117	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	0.000978	0.00116	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	0.000978	0.00116	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000976	0.00116	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000961	0.00114	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000956	0.00114	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CNR1—multiple sclerosis	0.00095	0.00113	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GPR65—multiple sclerosis	0.000937	0.00112	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCR2—multiple sclerosis	0.000935	0.00111	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000926	0.0011	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—POMC—multiple sclerosis	0.000918	0.00109	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCL2—multiple sclerosis	0.000898	0.00107	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000895	0.00107	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000886	0.00106	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000874	0.00104	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00087	0.00104	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CNR1—multiple sclerosis	0.000863	0.00103	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL13—multiple sclerosis	0.000857	0.00102	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR1—multiple sclerosis	0.000857	0.00102	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000856	0.00102	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000841	0.001	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	0.00084	0.001	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000836	0.000995	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000813	0.000968	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000803	0.000957	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000792	0.000943	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.00079	0.000941	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000777	0.000925	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000776	0.000924	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	0.000763	0.000908	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.000759	0.000904	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000757	0.000901	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000746	0.000888	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000737	0.000877	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.000729	0.000869	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.000725	0.000863	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	0.000725	0.000863	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000723	0.000861	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	0.000697	0.00083	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	0.000687	0.000818	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000677	0.000807	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	0.000671	0.000799	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	0.000669	0.000797	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000664	0.00079	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PGR—multiple sclerosis	0.00066	0.000786	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000657	0.000782	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000654	0.000779	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	0.000648	0.000771	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CD28—multiple sclerosis	0.000642	0.000764	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	0.00063	0.00075	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000623	0.000741	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	0.000611	0.000727	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	0.000603	0.000718	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000594	0.000707	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	0.000592	0.000704	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	0.000588	0.0007	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	0.000581	0.000692	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PGR—multiple sclerosis	0.000579	0.00069	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	0.000568	0.000676	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	0.000565	0.000673	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CD28—multiple sclerosis	0.000563	0.00067	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000561	0.000668	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000553	0.000658	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	0.000552	0.000658	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	0.000537	0.00064	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	0.000526	0.000626	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	0.000524	0.000623	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	0.000519	0.000618	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	0.000516	0.000615	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	0.00051	0.000607	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	0.000509	0.000607	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000502	0.000598	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	0.000497	0.000592	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PGR—multiple sclerosis	0.000489	0.000583	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	0.00048	0.000572	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	0.000477	0.000568	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CD28—multiple sclerosis	0.000476	0.000566	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	0.000471	0.000561	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	0.000467	0.000556	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	0.000461	0.000549	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	0.000459	0.000547	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CD86—multiple sclerosis	0.000458	0.000545	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	0.000451	0.000537	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	0.000438	0.000522	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	0.000437	0.000521	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	0.000431	0.000513	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	0.000418	0.000498	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	0.000417	0.000497	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	0.000406	0.000483	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CD86—multiple sclerosis	0.000401	0.000478	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	0.0004	0.000476	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	0.000398	0.000474	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	0.000397	0.000473	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	0.000395	0.000471	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	0.000389	0.000464	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	0.000388	0.000462	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	0.000383	0.000457	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOE—multiple sclerosis	0.000369	0.00044	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	0.000366	0.000436	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	0.000356	0.000424	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	0.000354	0.000421	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	0.000351	0.000418	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	0.000348	0.000415	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CD86—multiple sclerosis	0.000339	0.000404	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	0.000334	0.000398	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CD80—multiple sclerosis	0.000334	0.000398	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	0.000324	0.000386	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOE—multiple sclerosis	0.000324	0.000386	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—POMC—multiple sclerosis	0.000317	0.000378	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	0.00031	0.00037	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	0.000309	0.000368	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000304	0.000362	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	0.000301	0.000358	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	0.000297	0.000353	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	0.000294	0.00035	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CD80—multiple sclerosis	0.000293	0.000349	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	0.000282	0.000336	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—POMC—multiple sclerosis	0.000278	0.000331	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOE—multiple sclerosis	0.000274	0.000326	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	0.000272	0.000324	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000266	0.000317	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CD80—multiple sclerosis	0.000247	0.000295	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	0.000247	0.000294	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—POMC—multiple sclerosis	0.000235	0.00028	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL2—multiple sclerosis	0.000235	0.000279	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	0.000233	0.000278	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	0.00023	0.000274	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000225	0.000268	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	0.000222	0.000264	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	0.000209	0.000249	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL2—multiple sclerosis	0.000206	0.000245	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	0.000205	0.000244	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	0.000197	0.000235	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	0.000195	0.000232	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MYC—multiple sclerosis	0.000183	0.000218	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	0.000183	0.000218	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	0.000179	0.000214	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL2—multiple sclerosis	0.000174	0.000207	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	0.000173	0.000206	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	0.000173	0.000206	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	0.000165	0.000196	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MYC—multiple sclerosis	0.000161	0.000192	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	0.00016	0.000191	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	0.000157	0.000187	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	0.000146	0.000174	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6—multiple sclerosis	0.000138	0.000164	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MYC—multiple sclerosis	0.000136	0.000162	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	0.000136	0.000161	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	0.000133	0.000158	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6—multiple sclerosis	0.000121	0.000144	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6—multiple sclerosis	0.000102	0.000122	CbGpPWpGaD
